Software Equity Group

MARCH 13, 2023

Strategic buyers are publicly traded or privately owned software companies. Particularly notable is the significant decline in public strategic deals, which fell from 35% to 25% from 2021 to 2022. In previous economic downturns, such as 2008, private SaaS company valuations took a hit as public strategics were forced to cut back.

M&A 52

M&A Private Equity Equities S&P 52

Software Equity Group

FEBRUARY 12, 2024

In recent years, software buyers have been keenly focused on gross revenue retention (GRR) and gross profit margin (GPM) , largely because strong performance in these areas provides security amid uncertain economic conditions. But are they the same KPIs prospective buyers look at as they evaluate acquisition targets?

M&A 52

M&A Mergers and Acquisitions Business Valuation 52

Cooley M&A

JANUARY 22, 2021

While the decision was case-specific, we were all reminded of (i) the high bar of the MAE, particularly when changes are attributable to a systemic risk and (ii) the increasingly important role that covenants play with respect to deal certainty, particularly in periods of market and economic uncertainty. Buyer…Seller…PPP Lender? A Look Ahead.

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Software Equity Group

OCTOBER 22, 2024

In today’s economic climate, retention is everything: Software companies with Net Revenue Retention (NRR) rates above 120% are trading at a remarkable 63% premium over the market median. Improving Gross Margins : Focus on operational efficiency and pricing strategies to enhance profitability.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

JANUARY 25, 2023

Biopharmaceutical company Chimerix agreed to sell its worldwide rights to brincidofovir, including TEMBEXA, to Emergent BioSolutions in a transaction intended to enhance Chimerix’s balance sheet while allowing Chimerix to participate in the longer-term economics of the drug through milestone payments and royalties.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

For example, early in 2021, Zimmer Biomet Holdings announced that it would spin off its spine and dental businesses into a new publicly traded company as a way to “optimize resource allocation” among its remaining businesses. There is a history of drugs failing for one use and then being successfully developed for other uses.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

DECEMBER 20, 2024

In RCA, Cencora saw the opportunity to acquire additional profitability downstream of its existing operations. Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Focus Investment Banking

FEBRUARY 11, 2025

Traditional terminal exit routes for private equity-backed companies are to larger strategic acquirers (often public companies) and IPOs, where a private company becomes publicly traded. By acquiring the providers themselves, McKesson is securing a customer and capturing profitability downstream from its current operations.

Private Equity 52

Private Equity Healthcare Equities Medical 52